TB-500 and thymosin beta-4 are listed as synonyms across most of this market. They are related and they are not identical, and the difference is large enough that a single number on a certificate settles which one a supplier is holding.
That makes this an unusual purchase in one specific way: the most important pre-order question is not about quality but about identity, and it is answerable in one email.
What the two names actually describe
Thymosin beta-4 is a naturally occurring protein of substantial length, one of the more abundant intracellular proteins in many cell types. TB-500 is a designation attached to a synthetic fragment rather than the full-length molecule, covering a short motif from within the parent sequence.
Neither name is a registered designation with a single controlled meaning, which is why the market uses them interchangeably and why the label ends up describing a category rather than a molecule. TB-500 and thymosin beta-4 explained covers the relationship in detail.
The question that settles it
Ask which of the two the supplier holds, in mass terms rather than by name. The full-length protein and the shorter synthetic fragment differ substantially in mass, so one figure answers a question that no amount of label reading can.
Then ask what the certificate reports for identity. A mass consistent with the fragment on a product sold under the full-length name is not necessarily mislabelling, and it is a discrepancy worth having explained in writing before the order rather than afterwards.
Why this matters beyond pedantry
- Every downstream calculation uses the molecular weight, and the two figures are not close.
- Published work on the full-length protein is not describing the fragment, so a literature-based expectation formed from one has no basis applied to the other.
- Characterisation differs: a longer chain needs more from an identity method than a short motif does.
- A record naming only a product name cannot later establish which material was used.
What a complete answer looks like
| What you get | What it tells you |
|---|---|
| A product name only | Nothing about which molecule is in the vial |
| A stated sequence or fragment range | Which material is intended |
| A calculated mass that follows from it | That the supplier understands what they hold |
| A certificate whose observed mass agrees | That the material matches the intention |
A supplier describing a specific material can give all three. One describing a listing gives only the first.
Where the answer is incomplete, independent identity testing settles it directly and an accredited laboratory will accept a single sealed vial. Third-party testing and ISO/IEC 17025 covers what that accreditation establishes.
Reading the certificate
In the usual order, with identity carrying more weight than it would for a compound whose name is unambiguous. Lot against the vial first, then the two dates, then identity with its method named.
For the longer of the two materials, prefer an identity method that fragments the molecule over one that only weighs it, because a single intact mass establishes less as a molecule gets longer. Mass spectrometry and peptide identity covers the difference.
Choosing a strength
TB-500 is supplied across several strengths. The usual logic applies: larger vials are cheaper per milligram and that saving is only realised if the vial is finished before the material ages out, so size against consumption.
On a first order from an unfamiliar supplier, buy the smallest, because the purpose of a first order is to establish how the supplier documents their material rather than to stock up.
What to record
- The name as the supplier uses it, and the sequence or fragment range they state.
- The certificate mass, which is the figure that distinguishes the two materials.
- The lot, and your own copy of the certificate.
- The salt form, obtained by asking.
Those four together let anyone reading the record later establish which of the two materials was used, which a product name alone will not do.
Scope
TB-500 is supplied for laboratory research only. Nothing here describes effects in any organism. What documentation settles is which molecule is in the vial, how pure it is and how much of it there is.
In short
Two names, one market, materials of substantially different mass. Ask which one the supplier holds in mass terms, check the certificate agrees, record the sequence alongside the lot, and treat a supplier who cannot answer as having answered the purchasing question.
Choosing a supplier for an ambiguous name
The ordinary documentation checks apply and one additional question sits above them: can the supplier state, in mass terms, which of the two materials they hold. A supplier who can is describing a specific material. One who answers only with a product name is describing a listing.
That question also predicts how the rest of the relationship will go, because a supplier close enough to their manufacturing to answer it immediately is usually close enough to answer the next question too.
Reading the certificate for this compound
In the usual order, with identity carrying unusual weight. The lot against the vial first, then the two dates, then identity with its method named. For the longer of the two materials a single intact mass establishes less than a method that fragments the molecule and reads a ladder.
Then content as a measured mass rather than the label strength, and purity with its method and wavelength named. Reading a certificate of analysis line by line covers every field in order.
Handling
Dry and sealed, the material is comparatively robust, because lyophilisation removed the water that most degradation routes require. The clock that matters starts at reconstitution rather than delivery.
Once in solution, elapsed time and the number of entries into the vial both matter. Freeze-thaw cycles and aliquoting covers sizing aliquots so no tube is thawed twice, and vial closures covers why entries are a limit.
On arrival
- Match the lot on every vial to its certificate, reading the full string rather than the final characters.
- Confirm the observed mass on the certificate matches the material you believed you were ordering.
- Inspect the cake for collapse or discolouration, which is a finding worth raising.
- Record anything unexpected in writing before the material is put away.
Receiving and inspecting a peptide shipment is the ten-minute protocol this sits inside.
Choosing a strength
The usual logic. Larger vials are cheaper per milligram and the saving is only realised if the vial is finished before the material ages out, so size against consumption rather than unit price. Inventory levels and reorder points covers deriving that from measured usage.
Where this sits
For the relationship between the two names and what each describes, TB-500 and thymosin beta-4 explained. For the blend containing this compound, buying the BPC-157 and TB-500 blend.
Building the habit
The checks in this guide take minutes and they only work if they happen every time rather than when someone remembers. Two things make that realistic: a named person who owns receiving, and a form short enough that a busy day does not defeat it.
Writing an SOP for peptide receipt and storage covers turning the checks into something a practice actually follows, and chain of custody inside a practice covers the four points where the record usually breaks.
Why this is worth the extra question
Because almost every other pre-order check assumes you know which molecule you are buying. Purity, content and lot traceability are all answers about a material whose identity has been taken for granted, and here that assumption is the weakest link rather than the safest one.
Settling it first makes every subsequent check meaningful. Settling it late means re-reading documents you have already accepted.
A note on records
Record the sequence or fragment range alongside the lot, not just the product name. A year from now the product name will not distinguish the two materials and the sequence will, which is the whole point of writing it down.
Reading the quote
A wholesale quote carries four things: a unit price, a minimum quantity, the documentation included with the order, and the terms under which you pay. Only the first is read closely by most buyers and it is the one that tells you least about what the order will actually cost.
Documentation is the line that separates two identical-looking quotes, and terms change the real price more than the unit price does. Thirty days to pay on a four-figure order is worth roughly a month of the cost of capital. How to read a wholesale peptide quote takes all four apart.
One closing point specific to this compound. Where a quote names only a product, ask for the sequence before comparing prices, because two quotes may be for materials of substantially different mass and therefore not comparable at all.
A short pre-order checklist
Five questions, one email, about fifteen minutes. Can you send the certificate for a lot I would actually receive. Which laboratory issued it and what is it accredited for. Which salt form is supplied. What is the lead time for in stock against made to order. And what happens if a lot is withdrawn after I have taken delivery.
The answers matter and so does how they arrive: how quickly, whether they address what was asked, and whether they come from someone who can see the document rather than relaying it. Auditing a peptide supplier is the longer version, and comparing suppliers on documentation covers weighing the replies against each other.
This is one part of buying wholesale. Wholesale peptides for clinics covers the whole process from evaluating a supplier to placing a first order.